Accelerate Diagnostics | AXDX - Stock


Accelerate Diagnostics reported $3.22M in Stock for its fiscal quarter ending in June of 2024.



Stock Change Date
Abbott USD 6.99B 501M Mar/2026
Becton, Dickinson and Co. USD 4.08B 191M Dec/2025
Bio-Rad Laboratories USD 770.5M 29.8M Mar/2026
Bruker USD 1.09B 102M Dec/2025
Danaher USD 2.61B 119M Mar/2026
Illumina USD 611M 47M Mar/2026
Myriad Genetics USD 27.9M 2.7M Mar/2026
Pacific Biosciences Of California USD 49.28M 3.87M Dec/2025
Quidel USD 611.5M 33.9M Mar/2026
Revvity USD 387.5M 8.01M Mar/2026
Thermo Fisher Scientific USD 5.5B 71M Mar/2026